Obagi Medical Products, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$253.0M

418 transactions

Summary

Obagi Medical Products, Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $10KSales: $182.6M18 insiders

Date	Insider	Type	Value
2013-04-25	HUMMEL ALBERT F(President & CEO)	D	$1.9M
2013-04-25	HUMMEL ALBERT F(President & CEO)	D	$1.6M
2013-04-25	HUMMEL ALBERT F(President & CEO)	D	$1.1M
2013-04-25	Romm Preston S(CFO and Exec. VP)	D	$997K
2013-04-25	Goldstein David S.(Executive Vice President)	D	$780K
2013-04-25	Romm Preston S(CFO and Exec. VP)	D	$715K
2013-04-25	Goldstein David S.(Executive Vice President)	D	$715K
2013-04-25	Romm Preston S(CFO and Exec. VP)	D	$626K
2013-04-25	Goldstein David S.(Executive Vice President)	D	$626K
2013-04-25	Hunter Laura B.(VP and General Counsel)	D	$582K
2013-04-25	Romm Preston S(CFO and Exec. VP)	D	$565K
2013-04-25	Goldstein David S.(Executive Vice President)	D	$565K
2013-04-25	Taylor Mark Thomas(Senior Vice President)	D	$534K
2013-04-25	Hunter Laura B.(VP and General Counsel)	D	$357K
2013-04-25	Hunter Laura B.(VP and General Counsel)	D	$313K
2013-04-25	Taylor Mark Thomas(Senior Vice President)	D	$295K
2013-04-25	Hunter Laura B.(VP and General Counsel)	D	$283K
2013-04-25	Hunter Laura B.(VP and General Counsel)	D	$272K
2013-04-25	Goldstein David S.(Executive Vice President)	D	$262K
2013-04-25	Goldstein David S.(Executive Vice President)	D	$155K

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Obagi Medical Products, Inc. — Contributions, Lobbying & Contracts | Poliscope